Botox treatment

A legal dispute over a botox strain between South Korean pharmaceutical company Medytox Inc. and its crosstown rival Hugel Inc. has intensified with...

HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...

The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...

South Korean pharmaceutical company Medytox Inc. has filed a complaint with the International Trade Commission (ITC) against Hugel Inc., alleging th...

South Korea's SK Ecoplant Co. has acquired Singapore-based electronic waste (e-waste) disposal and recycling company TES Envirocorp Pte. Ltd for $1 ...

South Korea's biotech startup Novelty Nobility Inc. has signed a global license agreement for its antibody treatment candidate with a US biopharmace...

South Korea’s energy-to-retail conglomerate GS Group has increased its spending to become the largest shareholder in Hugel Inc., the country's...

Hyundai Engineering Co., the plant engineering and construction unit of South Korea’s Hyundai Motor Group, dropped a listing plan to raise up ...

South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...

South Korean SK Biopharmaceuticals Co. launched its epilepsy treatment Cenobamate in the UK, rapidly expanding the company’s presence in Europ...

Michael ByungJu Kim, the founder of South Korean investment firm MBK Partners, and Kim Jung-ju, founder of Nexon, the largest online gaming compan...

South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...

Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...

Hyundai Engineering Co., Hyundai Motor Group’s construction arm, has joined the race to buy a South Korean garbage treatment company as the gr...

South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...

A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...

South Korea’s pharmaceutical company Medytox Inc. has ended a botulinum toxin-related technology transfer contract with AbbVie, clouding its b...

Just like many other manufacturers around the world, 2020 was a turbulent year for Korea Zinc Co., the world’s largest lead and zinc smelter.T...

A consortium led by South Korea’s energy-to-construction conglomerate GS Group has acquired the country’s top botox maker Hugel Inc. fro...

South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...

Abu Dhabi’s sovereign investor Mubadala Investment Co. joined a consortium led by South Korean GS Group to acquire the country’s top bot...

South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...

South Korea’s Samsung Biologics Co. posted its highest quarterly revenue and operating profit, thanks largely to a number of long-term manufac...

The bid to acquire a controlling stake in Hugel Inc., South Korea’s leading maker of botulinum toxin, more commonly known as botox, from US pr...

Samsung Group is looking to buy a biopharmaceutical company as the top South Korean business conglomerate is resuming merger and acquisition activit...

South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...

There is money to be made in garbage. Such is the growing consensus among investors as well as waste treatment companies amid tighter environmental ...

Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...

A consortium led by South Korea’s GS Group is in talks to acquire a controlling stake in Hugel Inc., the country’s top maker of botulinu...

South Korean medical cosmetics companies that underwent a tough year in 2020 are posting rejuvenated earning results thanks to s rise in demand in E...